Literature DB >> 785955

Complication rates of selective percutaneous transfemoral coronary arteriography. A review of 1094 consecutive examinations.

S Nitter-Hauge, I Enge.   

Abstract

A review is presented of 1094 selective coronary artery studies during a 3-year period in which 7001 coronary artery injections were performed using the percutaneous transfemoral artery approach as described by Judkins. A total of 24 serious complications occurred, including 11 ventricular fibrillations, 5 asystoles or severe bradycardias, 3 acute myocardial infarctions and 5 cerebral vascular accidents. There were 5 deaths, giving an overall mortality rate of 0.46%. Causes of individual complications are analyzed. The incidence of serious cardiac complications did not differ significantly from that reported in the literature with the Sones technique. The Judkins technique is a simple and reliable method for selective coronary arteriography. In our opinion, the incidence of complications can be kept at an acceptably low level by meticulous examination techniques.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 785955     DOI: 10.1111/j.0954-6820.1976.tb08206.x

Source DB:  PubMed          Journal:  Acta Med Scand        ISSN: 0001-6101


  4 in total

1.  Complications of coronary arteriography.

Authors:  A Dodek; J A Boone; R O Hooper; D Kavanagh-Gray; I L Macdonald; D I Peretz
Journal:  Can Med Assoc J       Date:  1983-04-15       Impact factor: 8.262

2.  How safe is the coronary angiogram?

Authors:  D F Adams
Journal:  Cardiovasc Intervent Radiol       Date:  1982       Impact factor: 2.740

3.  Safety of the nonionic contrast medium omnipaque in coronary angiography.

Authors:  K Levorstad; K Vatne; U Brodahl; B Laake; S Simonsen; T Aakhus
Journal:  Cardiovasc Intervent Radiol       Date:  1989 Mar-Apr       Impact factor: 2.740

4.  Complications of aortic atherosclerosis: atheroemboli and thromboemboli.

Authors:  Theresa A Molisse; Paul A Tunick; Itzhak Kronzon
Journal:  Curr Treat Options Cardiovasc Med       Date:  2007-04
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.